EMEA-003248-PIP02-23 - paediatric investigation plan
Suvecaltamide (hydrochloride)
PIPHuman
Key facts
- Active Substance
- Suvecaltamide (hydrochloride)
- Therapeutic area
- Nervous system disorders
- Decision number
- P/0121/2024
- PIP number
- EMEA-003248-PIP02-23
- Pharmaceutical form(s)
- Capsule, hard
- Condition(s) / indication(s)
- Treatment of tremor in patients with Parkinson’s disease
- Route(s) of administration
- Oral use
- Contact for public enquiries
Jazz Pharmaceuticals Ireland Limited
E-mail: corporateaffairsmediainfo@jazzpharma.com
Tel: +353 16347800- Decision type
- W: decision granting a waiver in all age groups for all conditions or indications
- Decision date